The implications of our study are that inhibition of PCSK9 should be further considered as a novel therapeutic strategy for sepsis, and future research should focus on understanding the systemic effects and clinical outcomes of PCSK9 inhibition in patients with sepsis. This evidence concerns the gene PCSK9 and Sepsis.